• Home
  • About
      • Back
      • What is InFLAMES?
      • InFLAMES Organization
      • Steering group
      • SIAB
      • Postdocs in Flames (PiF)
      • Infrastructure
  • People
      • Back
      • People
      • Professors of Practice
      • Visiting Professors
      • Bioinformatics team
  • Education
      • Back
      • InFLAMES doctoral module
      • ImmuDocs Education Pilot
  • Output and Impact
      • Back
      • Recent Publications
      • Dissertations
  • News and Events
      • Back
      • News
      • Events
      • Blogs
      • Corporate Corner
      • Events archive
  • Join Us
      • Back
      • Vacancies
      • Partners
      • Why Finland?
  • Contact
      • Back
      • Contact
      • Reservation calendars
      • Research Managers
  • Suomi
  • Home
  • About
      • Back
      • What is InFLAMES?
      • InFLAMES Organization
      • Steering group
      • Scientific and Impact Advisory Board (SIAB)
      • Postdocs in Flames (PiF)
      • Infrastructure
  • People
      • Back
      • People
      • Professors of Practice
      • Visiting Professors
      • Bioinformatics team
  • Education
      • Back
      • InFLAMES doctoral module
      • ImmuDocs – National Doctoral Education Pilot Based on the Immune System
  • Output and Impact
      • Back
      • Recent Publications
      • Dissertations
  • News and events
      • Back
      • News
      • Upcoming events
      • Blogs
      • Corporate Corner
      • Events Archive
  • Join us
      • Back
      • Vacancies
      • Partners
      • Why Finland?
  • Contact us
      • Back
      • Contact
      • Reservation calendars
      • Research managers reservation calendar
  • Suomi

Author: Liisa Koivula

Timo Lappalainen appointed a Professor of Practice of pharmaceutical industry at the InFLAMES Flagship

16 January 2024
Timo Lappalainen appointed a Professor of Practice of pharmaceutical industry at the InFLAMES Flagship

ImmuDocs to train immunology specialists

29 December 2023
ImmuDocs to train immunology specialists

InFLAMES Flagship granted continued funding – first instalment €6.5 million

14 December 2023
InFLAMES Flagship granted continued funding – first instalment €6.5 million

Cancer therapy bexmarilimab awakens immune cells to attack tumours that have avoided the detection of the immune system

7 December 2023
Cancer therapy bexmarilimab awakens immune cells to attack tumours that have avoided the detection of the immune system

IMMUNOCAP: Positive, upward spiral for immunology research in Turku

15 November 2023
IMMUNOCAP: Positive, upward spiral for immunology research in Turku

Events finding their audience, or the other way around?

10 November 2023
Events finding their audience, or the other way around?

Unlocking the secrets of cell behaviour on soft substrates: A paradigm shift in mechanobiology

18 October 2023
Unlocking the secrets of cell behaviour on soft substrates: A paradigm shift in mechanobiology

How do I solve my problem like a bioinformatician?

10 October 2023
How do I solve my problem like a bioinformatician?

Science requires trust – reproducibility in bioinformatics

25 September 2023
Science requires trust – reproducibility in bioinformatics

Page 6 of 11

  • Prev
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next

About InFLAMES

Home

About us

Education

Output and Impact

Output and Impact

Partners

Information

Join us

Contact us

Join our newsletter mailing list or contact Us:

inflames@utu.fi
Follow us
© InFLAMES Research Flagship 2025